Daily Archives: April 20, 2020
Mon April 20 – 10 Stories of The Day!
20 Apr, 2020 | 00:29h | UTC
1 – Antibody tests suggest that coronavirus infections vastly exceed official counts – Nature
See original preprint study: COVID-19 Antibody Seroprevalence in Santa Clara County, California – medRxiv
Author interview: Dr. John Ioannidis Announces Results of COVID-19 Serology Study (video)
Other commentaries: Far more people may have been infected by coronavirus in one California county, study estimates – CNN AND The number of coronavirus infections in Santa Clara, California may be up to 85 times higher than testing shows, according to new research – Business Insider AND Up to 4% of Silicon Valley is already infected with coronavirus – MIT Technology Review
2 – The Promise and Peril of Antibody Testing for COVID-19 – JAMA
See also: Will antibody tests for the coronavirus really change everything? – Nature AND Antibody Test, Seen as Key to Reopening Country, Does Not Yet Deliver – The New York Times AND With Broad, Random Tests for Antibodies, Germany Seeks Path out of Lockdown
4 – The Science Underlying COVID-19: Implications for the Cardiovascular System – Circulation
Commentary: Priorities for Cath Labs in the COVID-19 Tsunami – American College of Cardiology
Related: Reperfusion of STEMI in the COVID-19 Era – Business as Usual? – Circulation AND As COVID-19 Spreads, US Cath Labs Ponder Fibrinolytics for STEMI – TCTMD
8 – What’s Happening With Remdesivir? – Science Translational Medicine
See also: Slow down your giddyup on Gilead news – Health News Review
Commentary: Study examines how Hong Kong managed first wave of COVID-19 without resorting to complete lockdown – The Lancet AND How Hong Kong dodged a major coronavirus outbreak without resorting to a complete lockdown using a combination of targeted isolation and social distancing – Daily Mail AND Expert reaction to paper assessing the impact of non- pharmaceutical interventions against COVID-19 in Hong Kong – Science Media Centre
10 – Coronavirus Disease (COVID-19) Updates / 20 April 2020 Edition
20 April 2020 Edition – COVID-19/SARS-CoV-2 Latest Articles, Guidelines, News & Perspectives (several free resources)
Antibody Tests Suggest that Coronavirus Infections Vastly Exceed Official Counts
20 Apr, 2020 | 00:25h | UTCAntibody tests suggest that coronavirus infections vastly exceed official counts – Nature
See original preprint study: COVID-19 Antibody Seroprevalence in Santa Clara County, California – medRxiv
Author interview: Dr. John Ioannidis Announces Results of COVID-19 Serology Study (video)
Other commentaries: Far more people may have been infected by coronavirus in one California county, study estimates – CNN AND The number of coronavirus infections in Santa Clara, California may be up to 85 times higher than testing shows, according to new research – Business Insider AND Up to 4% of Silicon Valley is already infected with coronavirus – MIT Technology Review
The Promise and Peril of Antibody Testing for COVID-19
20 Apr, 2020 | 00:23h | UTCThe Promise and Peril of Antibody Testing for COVID-19 – JAMA
See also: Will antibody tests for the coronavirus really change everything? – Nature AND Antibody Test, Seen as Key to Reopening Country, Does Not Yet Deliver – The New York Times AND With Broad, Random Tests for Antibodies, Germany Seeks Path out of Lockdown
How Does Coronavirus Kill?
20 Apr, 2020 | 00:21h | UTC
Review: COVID-19 and Thrombotic or Thromboembolic Disease
20 Apr, 2020 | 00:18h | UTC
Priorities for Cath Labs in the COVID-19 Tsunami
20 Apr, 2020 | 00:15h | UTCCommentary: Priorities for Cath Labs in the COVID-19 Tsunami – American College of Cardiology
Related: Reperfusion of STEMI in the COVID-19 Era – Business as Usual? – Circulation AND As COVID-19 Spreads, US Cath Labs Ponder Fibrinolytics for STEMI – TCTMD
The Science Underlying COVID-19: Implications for the Cardiovascular System
20 Apr, 2020 | 00:19h | UTCThe Science Underlying COVID-19: Implications for the Cardiovascular System – Circulation
Impact of Non-pharmaceutical Interventions Against COVID-19 and Influenza in Hong Kong
20 Apr, 2020 | 00:11h | UTCCommentary: Study examines how Hong Kong managed first wave of COVID-19 without resorting to complete lockdown – The Lancet AND How Hong Kong dodged a major coronavirus outbreak without resorting to a complete lockdown using a combination of targeted isolation and social distancing – Daily Mail AND Expert reaction to paper assessing the impact of non- pharmaceutical interventions against COVID-19 in Hong Kong – Science Media Centre
Related Commentary on Twitter
The Hong Kong admirable strategy that got way ahead of #COVID19 also extended to reducing the influenza. We can all learn so much from this:https://t.co/wHKijEmVi7 @TheLancetPH by @hkumed @gmleunghku @bencowling88 and their colleagues pic.twitter.com/pO5PFjx8jO
— Eric Topol (@EricTopol) April 17, 2020
Editorial: COVID-19 Pneumonia: ARDS or Not? – Critical Care
20 Apr, 2020 | 00:09h | UTCEditorial: COVID-19 pneumonia: ARDS or not? – Critical Care
Related: COVID-19 pneumonia: different respiratory treatment for different phenotypes? – Intensive Care Medicine AND Covid-19 Does Not Lead to a “Typical” Acute Respiratory Distress Syndrome – American Journal of Respiratory and Critical Care Medicine
Disruptive Modifications to Cardiac Critical Care Delivery During the Covid-19 Pandemic
20 Apr, 2020 | 00:14h | UTC
What’s Happening with Remdesivir?
20 Apr, 2020 | 00:12h | UTCWhat’s Happening With Remdesivir? – Science Translational Medicine
See also: Slow down your giddyup on Gilead news – Health News Review
Defining ARDS & Recruitability, with Implications for COVID Treatment
20 Apr, 2020 | 00:06h | UTCDefining ARDS & recruitability, with implications for COVID treatment – PulmCrit
Hospital Preparedness for COVID-19: A Practical Guide from a Critical Care Perspective
20 Apr, 2020 | 00:07h | UTC
WHO Interim Guidance: Safe Ramadan Practices in the Context of the COVID-19
20 Apr, 2020 | 00:04h | UTCSafe Ramadan practices in the context of the COVID-19 – World Health Organization
Africa Covid-19 Report: At Least 300.000 People Could Lose Their Lives as a Direct Result of COVID-19
20 Apr, 2020 | 00:05h | UTCCOVID-19 in Africa: Protecting Lives and Economies – United Nations Economic Commission for Africa
News Release: COVID-19 in Africa: Protecting Lives and Economies – United Nations Economic Commission for Africa
Commentary: Africa could see 300,000 or more coronavirus deaths this year, report says – The Globe and Mail AND U.N. Agency Fears ‘Vulnerable’ Africa May Suffer At Least 300,000 COVID-19 Deaths – NPR
COVID-19 Outbreak Associated with Air Conditioning?
20 Apr, 2020 | 00:03h | UTC
Observational Study: Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Seems Safe Among Patients with Hypertension Hospitalized With COVID-19
20 Apr, 2020 | 00:01h | UTC
COVID-19 and Renin Angiotensin Blockers: Current Evidence and Recommendations
20 Apr, 2020 | 00:00h | UTCCOVID-19 and Renin Angiotensin Blockers: Current Evidence and Recommendations – Circulation
Commentary: COVID-19 and Renin Angiotensin Blockers – American College of Cardiology